Literature DB >> 8991539

Dendritic cells: origin and differentiation.

R Thomas1, P E Lipsky.   

Abstract

Dendritic cells (DC) are bone marrow-derived cells that are specialized to take up, process and present antigen, and have the capacity to stimulate resting T cells in the primary immune response. DC are a unique population that is likely to derive from a myeloid precursor cell. DC differentiation from bone marrow precursors in enhanced by the cytokines GM-CSF and tumor necrosis factor-alpha. In contrast, it has been proposed that thymic DC and T cells arise from a common stem cell, and that these DC play a specific role in the negative selection of thymic T cells. A number of post-bone marrow differentiation stages can be defined phenotypically and functionally. Undifferentiated DC have very active endocytic pathways, including receptor-mediated endocytosis involving a mannose/beta glucan receptor, and macropinocytosis of soluble antigen. In contrast, later stages of maturation are associated with a decreased ability to take up and process antigen, and increasing expression of major histocompatibility complex, adhesion and costimulatory molecules. Finally, activation of DC for full antigen-presenting cell function can be identified by the expression of CD28 ligands. The inflammatory site in rheumatoid arthritis is a human model of DC differentiation in response to a chronic antigenic stimulus. The features of this DC model are discussed.

Entities:  

Mesh:

Year:  1996        PMID: 8991539     DOI: 10.1002/stem.140196

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  9 in total

Review 1.  Antigen-presenting cells in rheumatoid arthritis.

Authors:  R Thomas
Journal:  Springer Semin Immunopathol       Date:  1998

2.  Identification of novel macropinocytosis inhibitors using a rational screen of Food and Drug Administration-approved drugs.

Authors:  Hui-Ping Lin; Bhupesh Singla; Pushpankur Ghoshal; Jessica L Faulkner; Mary Cherian-Shaw; Paul M O'Connor; Jin-Xiong She; Eric J Belin de Chantemele; Gábor Csányi
Journal:  Br J Pharmacol       Date:  2018-08-01       Impact factor: 8.739

3.  Alcohol exposure impairs myeloid dendritic cell function in rhesus macaques.

Authors:  Robert W Siggins; Gregory J Bagby; Patricia Molina; Jason Dufour; Steve Nelson; Ping Zhang
Journal:  Alcohol Clin Exp Res       Date:  2009-05-26       Impact factor: 3.455

Review 4.  Cells of the synovium in rheumatoid arthritis. Dendritic cells.

Authors:  Viviana Lutzky; Suad Hannawi; Ranjeny Thomas
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

5.  Hepatitis B e Antigen Seroconversion Is Related with the Function of Dendritic Cells in Chronic Hepatitis B Virus Infection.

Authors:  Chunjing Lin; Hai Zou; Shumin Wang
Journal:  Gastroenterol Res Pract       Date:  2014-12-09       Impact factor: 2.260

6.  Dextromethorphan inhibits activations and functions in dendritic cells.

Authors:  Der-Yuan Chen; Pei-Shan Song; Jau-Shyong Hong; Ching-Liang Chu; I-Horng Pan; Yi-Ming Chen; Ching-Hsiung Lin; Sheng-Hao Lin; Chi-Chen Lin
Journal:  Clin Dev Immunol       Date:  2013-05-28

7.  The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand.

Authors:  G Grouard; M C Rissoan; L Filgueira; I Durand; J Banchereau; Y J Liu
Journal:  J Exp Med       Date:  1997-03-17       Impact factor: 14.307

8.  Indeterminate cell histiocytosis successfully treated with phototherapy.

Authors:  Maria Claudia Nogueira Zerbini; Mirian Nacagami Sotto; Fernando Peixoto Ferraz de Campos; Andre Neder Ramires Abdo; Juliana Pereira; José Antônio Sanches; Jade Cury Martins
Journal:  Autops Case Rep       Date:  2016-06-30

9.  Change in the immune function of porcine iliac artery endothelial cells infected with porcine circovirus type 2 and its inhibition on monocyte derived dendritic cells maturation.

Authors:  Ning Yang; Jinzeng Qiao; Shiyu Liu; Zhanming Zou; Linlin Zhu; Xinyu Liu; Shuanghai Zhou; Huanrong Li
Journal:  PLoS One       Date:  2017-10-26       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.